As of today (2024-06-20), the Forward Annual Dividend Yield of Maxigen Biotech is 1.08%.
As of today (2024-06-20), the Trailing Annual Dividend Yield of Maxigen Biotech is 1.08%.
TPE:1783's Forward Dividend Yield % is ranked worse than 70.82% of 305
companies
in the Medical Devices & Instruments industry
Industry Median: 1.84
vs TPE:1783: 1.08
During the past 3 years, the average Dividends Per Share Growth Rate was -9.50% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Maxigen Biotech was 69.50% per year. The lowest was -9.50% per year. And the median was 30.00% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Competitive Comparison of Maxigen Biotech's Forward Dividend Yield %
For the Medical Instruments & Supplies subindustry, Maxigen Biotech's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Maxigen Biotech's Forward Dividend Yield % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Maxigen Biotech's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Maxigen Biotech's Forward Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Maxigen Biotech Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
TWD 0.500000
2023-09-07
2023-09-08
2023-10-12
Cash Dividend
annually
TWD:TWD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Maxigen Biotech's Forward Annual Dividend Yield (%) for Today is calculated as
Forward Annual Dividend Yield
=
Forward Full Year Dividend
/
Current Share Price
=
0.5
/
45.70
=
1.09 %
Current Share Price is NT$45.70. Maxigen Biotech's Dividends per Share for the forward twelve months is calculated as NT$0.5 * 1 = NT$0.5.
Maxigen Biotech's Trailing Annual Dividend Yield (%) for Today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Maxigen Biotech Forward Dividend Yield % Related Terms
Thank you for viewing the detailed overview of Maxigen Biotech's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Maxigen Biotech Inc specializes in the developing, manufacturing, and marketing of biomedical and cosmeceutical skincare products. It provides medical devices for orthopedic, ophthalmic, dental, and surgical applications. Skincare product categories include mask series, facial cleansing series, and body care series. The biomedical products segment is primarily engaged in the manufacturing and sales of collagen and bone materials, which forms the majority chunk of the revenue of the group. The consumer products segment is engaged in the manufacturing and sales of beauty care products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TPE:1783 has been successfully added to your